Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies

Typical crystallizable fragment (Fc) glycans attached to the CH2 domain in therapeutic monoclonal antibodies (mAbs) are core-fucosylated and asialo-biantennary complex-type glycans, e.g., G2F (full galactosylation), G1aF (terminal galactosylation on the Man α1-6 arm), G1bF (terminal galactosylation...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoyama, Michihiko, Hashii, Noritaka, Tsukimura, Wataru, Osumi, Kenji, Harazono, Akira, Tada, Minoru, Kiyoshi, Masato, Matsuda, Akio, Ishii-Watabe, Akiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601563/
https://www.ncbi.nlm.nih.gov/pubmed/30990348
http://dx.doi.org/10.1080/19420862.2019.1608143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601563/
https://www.ncbi.nlm.nih.gov/pubmed/30990348
http://dx.doi.org/10.1080/19420862.2019.1608143

Ejemplares similares